| Sr. Sales Executive-BC |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Nov. 19, 2024 |
| Medical Science Liaison-Oncology-Breast Cancer |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Research & Development |
Nov. 14, 2024 |
| (Senior) Market Access Manager |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Market Access |
Nov. 12, 2024 |
| (Sr.) Sales Executive-Solid Tumor |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Nov. 04, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 28, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 28, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 28, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 28, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 28, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 28, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 28, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 28, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 28, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 28, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 28, 2024 |
| (Senior) Medical Advisor (Radioligand Therapy) |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Research & Development |
Okt. 09, 2024 |
| Associate Sales Manager |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Juli 18, 2024 |
| (Sr.) Sales Executive-OPH |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Juni 12, 2024 |